Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Equol is a nonsteroidal estrogen produced by the metabolism of the soy isoflavone daidzein by gut bacteria. Its use to support or treat breast swelling and tenderness—often associated with cyclical mastalgia or perimenstrual symptoms—has some scientific basis, though the evidence is still emerging. Equol is a selective estrogen receptor modulator (SERM), and it binds preferentially to estrogen receptor beta (ERβ), which may have anti-proliferative and anti-inflammatory effects in breast tissue. Several studies have shown that individuals who produce equol naturally from soy isoflavones may experience fewer menopausal symptoms, including breast tenderness, compared to non-producers.

A few small-scale clinical trials and observational studies suggest that supplementation with equol or a diet high in soy isoflavones is associated with a reduction in breast pain and swelling in some women, particularly those experiencing perimenopausal or premenstrual symptoms. However, large-scale, randomized controlled trials specifically targeting breast swelling and tenderness are lacking, and much of the evidence is extrapolated from broader studies on menopausal symptoms and estrogen modulation.

In summary, equol's use for breast swelling and tenderness is scientifically plausible and somewhat supported by preliminary studies and mechanistic rationale, but robust clinical evidence is still limited. The current rating reflects moderate support with a need for more targeted research.

More about Equol (proprietary)
More about Breasts (swelling and tenderness)

Other ingredients used for Breasts (swelling and tenderness)

Other health conditions supported by Equol (proprietary)

Products containing Equol (proprietary)

Nature's Sunshine Equolibrium™